Νicolas Tsavaris

2.2k total citations
87 papers, 1.7k citations indexed

About

Νicolas Tsavaris is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Νicolas Tsavaris has authored 87 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 32 papers in Pulmonary and Respiratory Medicine and 24 papers in Surgery. Recurrent topics in Νicolas Tsavaris's work include Colorectal Cancer Treatments and Studies (22 papers), Cancer Treatment and Pharmacology (20 papers) and Lung Cancer Treatments and Mutations (14 papers). Νicolas Tsavaris is often cited by papers focused on Colorectal Cancer Treatments and Studies (22 papers), Cancer Treatment and Pharmacology (20 papers) and Lung Cancer Treatments and Mutations (14 papers). Νicolas Tsavaris collaborates with scholars based in Greece, United States and Russia. Νicolas Tsavaris's co-authors include Christos Kosmas, Petros Kopterides, Maria Vadiaka, John Syrios, H. Skopelitis, A. Karabelis, Manolis S. Kallistratos, Aristidis Polyzos, Nikolaos Malamos and P. Kosmidis and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Νicolas Tsavaris

84 papers receiving 1.6k citations

Peers

Νicolas Tsavaris
M Forni France
K. Syrigos Greece
Süleyman Buyukberber Türkiye
G Brufman Israel
Don V. Jackson United States
Massimo Lopez Italy
Jean Marc Extra France
Chueh‐Chuan Yen Taiwan
David Nathanson United States
Evans We United States
M Forni France
Νicolas Tsavaris
Citations per year, relative to Νicolas Tsavaris Νicolas Tsavaris (= 1×) peers M Forni

Countries citing papers authored by Νicolas Tsavaris

Since Specialization
Citations

This map shows the geographic impact of Νicolas Tsavaris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Νicolas Tsavaris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Νicolas Tsavaris more than expected).

Fields of papers citing papers by Νicolas Tsavaris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Νicolas Tsavaris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Νicolas Tsavaris. The network helps show where Νicolas Tsavaris may publish in the future.

Co-authorship network of co-authors of Νicolas Tsavaris

This figure shows the co-authorship network connecting the top 25 collaborators of Νicolas Tsavaris. A scholar is included among the top collaborators of Νicolas Tsavaris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Νicolas Tsavaris. Νicolas Tsavaris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalotychou, Vassiliki, et al.. (2016). ecancermedicalscience. ecancermedicalscience. 8. 428–428. 22 indexed citations
2.
Syrios, John, et al.. (2012). Prolonged survival after sequential multimodal treatment in metastatic renal cell carcinoma: two case reports and a review of the literature. Journal of Medical Case Reports. 6(1). 303–303. 4 indexed citations
3.
4.
Kosmas, Christos, Νicolas Tsavaris, Nikolaos Malamos, et al.. (2007). Docetaxel–ifosfamide combination in patients with HER2-non-overexpressing advanced breast cancer failing prior anthracyclines. Investigational New Drugs. 25(5). 463–470.
5.
Kopterides, Petros, Eleni G. Mourtzoukou, Elias Skopelitis, Νicolas Tsavaris, & Matthew E. Falagas. (2007). Aspects of the association between leishmaniasis and malignant disorders. Transactions of the Royal Society of Tropical Medicine and Hygiene. 101(12). 1181–1189. 59 indexed citations
6.
Kosmas, Christos, Manolis S. Kallistratos, Petros Kopterides, et al.. (2007). Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study. Journal of Cancer Research and Clinical Oncology. 134(1). 75–82. 236 indexed citations
7.
Tsavaris, Νicolas, et al.. (2006). Spontaneous remission of acute myeloid leukemia associated with GnRH agonist treatment. Leukemia & lymphoma. 47(3). 557–560. 3 indexed citations
8.
Kosmas, Christos, Νicolas Tsavaris, Konstantinos Syrigos, et al.. (2006). A phase I–II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens. Cancer Chemotherapy and Pharmacology. 59(1). 51–59. 20 indexed citations
9.
Tsavaris, Νicolas, et al.. (2005). Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study. Investigational New Drugs. 23(4). 369–375. 86 indexed citations
10.
Lazaris, Andreas C., et al.. (2002). Markers of drug resistance in relapsing colon cancer. Journal of Cancer Research and Clinical Oncology. 128(2). 114–118. 32 indexed citations
11.
12.
Tsavaris, Νicolas, Aris Polyzos, Christos Kosmas, et al.. (2002). Irinotecan (CPT-11) in Patients with Advanced Colon Carcinoma Relapsing after 5-Fluorouracil-Leucovorin Combination. Chemotherapy. 48(2). 94–99. 15 indexed citations
13.
Kosmas, Christos, Νicolas Tsavaris, Maria Vadiaka, et al.. (2001). Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens. European Journal of Cancer. 37(8). 972–978. 32 indexed citations
14.
Kosmidis, P., C. Bacoyiannis, George Fountzilas, et al.. (1997). 5-Fluorouracil, interferon-α-2b and cisplatin (FAP) for advanced urothelial cancer. A phase II study. Annals of Oncology. 8(4). 373–378. 9 indexed citations
15.
Bafaloukos, Dimitrios, N. Pavlidis, D. Skarlos, et al.. (1996). Recombinant Interferon ALFA-2A in Combination With Carboplatin, Vinblastine, and Bleomycin in the Treatment of Advanced Malignant Melanoma. American Journal of Clinical Oncology. 19(3). 296–300. 9 indexed citations
16.
Tsavaris, Νicolas, et al.. (1995). 5-Fluorouracil, folinic acid and cisplatin in advanced colorectal cancer. Anti-Cancer Drugs. 6(4). 599–603. 1 indexed citations
17.
Tsavaris, Νicolas, et al.. (1994). Comparison of Ondansentron (GR 38032F) Versus Ondansentron plus Alprazolam as Antiemetic Prophylaxis During Cisplatin-Containing Chemotherapy. American Journal of Clinical Oncology. 17(6). 516–521. 6 indexed citations
18.
Tsavaris, Νicolas, et al.. (1992). A randomized prospective study of cisplatin and vinblastine versus cisplatin, vinblastine and mitomycin in advanced non-small cell lung cancer. Annals of Oncology. 3(2). 127–130. 14 indexed citations
19.
Tsavaris, Νicolas, et al.. (1992). Continuous 24-Hour Infusion of Folinic Acid Does Not Increase the Response Rate of 5-Fluorouracil but Only the Toxicity. Oncology. 49(2). 154–156. 1 indexed citations
20.
Tsavaris, Νicolas, et al.. (1991). Decreased Oral Toxicity with the Local Use of Allopurinol in Patients Who Received High Dose 5-Fluorouracil. PubMed. 7(3). 113–117. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Forni Breakdown of academic impact, for papers by K. Syrigos Breakdown of academic impact, for papers by Süleyman Buyukberber Breakdown of academic impact, for papers by G Brufman Breakdown of academic impact, for papers by Don V. Jackson Breakdown of academic impact, for papers by Massimo Lopez Breakdown of academic impact, for papers by Jean Marc Extra Breakdown of academic impact, for papers by Chueh‐Chuan Yen Breakdown of academic impact, for papers by David Nathanson Breakdown of academic impact, for papers by Evans We
Rankless by CCL
2026